Nitric oxide-donating prostaglandin F analog
This page covers all Nitric oxide-donating prostaglandin F analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostaglandin F receptor (FP receptor); nitric oxide pathway.
Targets
Prostaglandin F receptor (FP receptor); nitric oxide pathway
Phase 3 pipeline (1)
- NCX 470 0.1% · Nicox Ophthalmics, Inc. · Ophthalmology
NCX 470 is a nitric oxide-donating prostaglandin F analog that lowers intraocular pressure by increasing uveoscleral outflow and releasing nitric oxide to enhance trabecular outflow.
Patent intelligence
- nitric oxide donating prostaglandin f analog patent landscape — aggregated cliff calendar, attackable patents, originator estates